Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia
1 clinical trials · Condition
◉ Watch Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia
| Record | Firm | Date |
|---|---|---|
| A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced Neutropenia (NCT02044276) | Teva Branded Pharmaceutical Products R&D, Inc. | 2014-03-31 |
Track Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia automatically
Every clearance here is in the API, with alerts when new ones post.